Chemoprevention of contralateral breast cancer with the synthetic retinoid fenretinide

Umberto Veronesi, Alberto Costa

Research output: Contribution to journalArticlepeer-review


The Milan Cancer Institute has been involved in clinical research on breast cancer for the last 25 years, and although the previous studies have been mainly concerned with trials aimed at refining the chemotherapy, radiotherapy, and surgical procedures, in recent years we have been progressively interested in detection and prevention programs. In this latter context, we have developed a special interest in research in chemoprevention with retinoids.

Original languageEnglish
Pages (from-to)639-641
Number of pages3
JournalCancer Investigation
Issue number5
Publication statusPublished - 1988

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Chemoprevention of contralateral breast cancer with the synthetic retinoid fenretinide'. Together they form a unique fingerprint.

Cite this